In patients with RIT1-associated Noonan Syndrome, a MEK inhibitor called trametinib was found to reverse hypertrophic cardiomyopathy (HCM) and valvular obstruction. Noonan syndrome is a rare genetic syndrome.
from Medindia Health News http://bit.ly/2WiEE2V
No comments:
Post a Comment